American Healthcare REIT Reports Strong Q1 Operational Growth, Raises NFFO Guidance Amid Significant Dilution and GAAP EPS Cut
AHR sits 54% above its 52-week low of $32.15.
Summary
American Healthcare REIT reported strong Q1 operational results and raised NFFO guidance, but cut full-year GAAP EPS guidance and executed substantial dilutive equity sales under its ATM program.
Key Events · Earnings and Guidance · AHR
-
Strong Q1 Operational Performance
Reported GAAP net income of $23.7 million ($0.13 per diluted share) and Normalized Funds From Operations (NFFO) of $0.50 per diluted share, representing over 30% growth year-over-year. Total portfolio Same-Store Net Operating Income (NOI) grew by 12.1%.
-
Mixed Full-Year 2026 Guidance Update
Increased full-year NFFO per diluted share guidance to $2.03-$2.09 and total portfolio Same-Store NOI growth guidance to 9.0%-12.0%. However, full-year GAAP net income per diluted share guidance was significantly decreased to $0.51-$0.57 from $0.75-$0.81.
-
Significant Dilutive Capital Raise
Issued 6,730,727 shares for $325.2 million in gross proceeds through its ATM program and November 2025 equity offering. Additionally, entered into new forward sale agreements for 9,589,747 shares, expected to generate $481.1 million in gross proceeds, bringing total capital activity to $806.3 million. This represents approximately 8.4% potential dilution based on current market capitalization.
-
Balance Sheet Strengthening and Acquisitions
Net Debt-to-Annualized Adjusted EBITDA improved to 3.0x from 3.4x. The unsecured revolving credit facility was increased from $600 million to $800 million. The company acquired $162.8 million in new SHOP assets during Q1 and an additional $86.4 million subsequent to quarter-end, while selling $8.1 million in non-core properties.
Analysis · AHR · Real Estate & Construction
American Healthcare REIT reported a mixed but highly impactful first quarter. While the company demonstrated strong operational performance with double-digit Same-Store NOI growth and increased NFFO guidance, it also announced a substantial reduction in its full-year GAAP net income per diluted share guidance. Furthermore, the company continued to utilize its At-The-Market (ATM) equity offering program, resulting in significant dilution to fund acquisitions and improve its balance sheet. Investors should weigh the positive operational momentum and balance sheet improvements against the considerable dilution and the lowered GAAP earnings outlook, which could pressure the stock.
At the time of this filing, AHR was trading at $49.60 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.6B. The 52-week trading range was $32.15 to $54.67. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.